Perampanel and Infection - a phase IV clinical study of FDA data

Summary:

Infection is reported as a side effect among people who take Perampanel (perampanel), especially for people who are male, 20-29 old, also take Lacosamide, and have Status epilepticus.

The phase IV clinical study analyzes which people have Infection when taking Perampanel. It is created by eHealthMe based on reports of 2,473 people who have side effects when taking Perampanel from the FDA, and is updated regularly.

What is Perampanel?

Perampanel has active ingredients of perampanel. eHealthMe is studying from 2,474 Perampanel users. Check the latest studies of Perampanel.

What is Infection?

Infection is found to be associated with 2,497 drugs and 2,595 conditions by eHealthMe. Check the latest studies of Infection.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Jul, 03, 2026

2,473 people reported to have side effects when taking Perampanel.
Among them, 17 people (0.69%) have Infection.

Among these 17 people:

What is the gender of people who have Infection when taking Perampanel? *

female: 11.76 %
male: 88.24 %

What is the age of people who have Infection when taking Perampanel? *

What are other drugs people take besides Perampanel? *

What are other side effects people have besides Infection? *

Weight Decreased: 13 people, 76.47%
Liver Function Test Abnormal: 13 people, 76.47%
Anaemia (lack of blood): 13 people, 76.47%
Fungal Infection: 13 people, 76.47%
Muscle Contracture (a permanent shortening of a muscle): 13 people, 76.47%
Thrombophlebitis (swelling (inflammation) of a vein caused by a blood clot): 13 people, 76.47%
Cognitive Disorder (mental health disorders affects learning, memory, perception, and problem solving): 12 people, 70.59%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 12 people, 70.59%
Arrhythmias (irregular heartbeat): 10 people, 58.82%
Fever: 10 people, 58.82%

What are the existing conditions these people have? *

Status Epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure): 13 people, 76.47%
Sedation: 11 people, 64.71%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 6 people, 35.29%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 5 people, 29.41%
Movement Disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness): 1 person, 5.88%
Immunodeficiency Disorders: 1 person, 5.88%
Encephalitis Autoimmune (autoimmune origin disturbances of consciousness and pyramidal signs, inflammation of the brain): 1 person, 5.88%
Dyskinesia (abnormality or impairment of voluntary movement): 1 person, 5.88%
Clonic Convulsion (long lasting seizure): 1 person, 5.88%
Brain Abscess: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Perampanel and have Infection?

- Check whether Infection is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Perampanel:

Perampanel (2,474 reports)

Infection treatments and more:

Infection (201,699 reports)

Browse all side effects of Perampanel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Infection:

Infection (2,497 drugs)

Browse all the conditions that are associated with Infection:

Infection (2,595 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on perampanel (the active ingredients of Perampanel) and Perampanel (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.